Healthy Ideas, Healthy Returns offers 4 times a year free lunch webinars, open to all Spin off teams and KTO-staff, connected to our member institutions.

Regulatory affairs in MedTech - 30 September, 2021 - 12.00-13.00 and a seperate edition on Regulatory affairs in Diagnostics - 21 October, 2021 - 12.00-13.00

Welcome to our 3rd free HIHR lunch webinar of this year given by Qualix, a partner in Quality Assurance and Regulatory Affairs

In consultation with Qualix, we have decided to split up our third free lunch webinar, this time on Regulatory affairs into two separate sessions, as it was considered too short time to cover both topics properly in one single session.

Thursday 30 September from 12.00 – 13.00, we will focus on Regulatory affairs in Medtech.
Thursday October 21, 12.00 – 13.00  a second edition will cover Regulatory affairs in Diagnostics.

This online session will start with an introduction on:
– IVDR/MDR legislative framework
– Regulatory roadmap for new MedTech projects
– Challenges to consider when bringing a medical device to the market
and will be followed by a Q&A session.
The second edition will focus on the specifics in the Diagnostics area.

The webinar will be given by Pascale Van Hoydonck – senior consultant (long track record as EMEA Regulatory affairs director in MedTech industry) and/or Ruth Beckers – founder/senior consultant (long track record as quality and regulatory affairs consultant for MedTech industry) from Qualix.

Please send an email to if you want to participate to one of these or both webinars and reserve your seat.

How to boost the chances of your project success from day one (and secure the investors' money too) - 20 April 2021, by INKEF Capital

A recorded version of the webinar is available for spin off teams and staff of HIHR-institutions for internal use only.
Please send an email to to receive the link.

The webinar, hosted by INKEF Capital, an early stage VC in technology and healthcare, provides an inside look into the venture capital decision making process and its key drivers. The speakers Ivan Burkov and Simone Botti bring up a few real-life cases that exemplify the concept of “investability” and showcase how one can approach potential project planning to maximize its chances of securing funding.

The program consists of a presentation of 45 minutes on the following topics:
– intro on Inkef
– three important things to take into account when starting a biotech
– the VC world
– what do investors look for and how to maximize your fundraising chance
followed by 15 to 20 minutes Q&A.

IP Due diligence in Spin off creation - February 9 2021

LC Patents - Arnold & Siedsma

A recorded version of the webinar is available for spin-off teams and staff of HIHR-institutions for internal use only.
Please send an email to to receive the link.

Scope of the webinar is how to prepare an IP Due Diligence; pitfalls and take home messages, plus the merit of having this in place to strengthen your file for investors.

Three short modules of 15 minutes each will deal with:
1. Data Rooms and what it takes to manage this.
    When do you start building the data room? What requirements must it meet? How does an IP due diligence work?
2. DD on patents / FTO (Freedom to Operate)
    What ways are there to perform an FTO? Why is this so important? What requirements must the FTO meet?
3. DD on IP Contracts.
    What should you pay attention to? What are the pitfalls and what conditions do you have to meet?

The webinar was hosted by Arnold & Siedsma / LC Patents, a full service provider in the field of intellectual property. And the presentation was given by Nick Schopman and Michiel Rijsdijk, partner and attorney-at-law at Arnold & Siedsma / LC Patents. Nick is a European and Dutch patent attorney and has a background in Biotechnology and obtained his PhD in Immunology and Virology at the Amsterdam Medical Centre. 

We warmly welcome you to join us at one of our webinars!

45 Participating academic institutions in the Benelux (not all logos included)

Radboud umc
Wageningen University & Research

Preferred partner

Silver partners